Bulletin
Investor Alert

Market Pulse Archives

June 10, 2021, 8:14 a.m. EDT

Moderna files for its COVID-19 vaccine to be granted emergency use in adolescents

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    Pfizer Inc. (PFE)
  • X
    BioNTech SE ADR (BNTX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Moderna Inc. /zigman2/quotes/205619834/composite MRNA +2.30% said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket trading. In May, the biotechnology company said the vaccine efficacy in the nearly 2,500 participants aged 12 to less than 18 years who received its COVID-19 vaccine was observed to be 100% when using the same case definition as in the Phase 3 study in adults. "We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents," said Chief Executive Stéphane Bancel. "We have already filed for authorization with Health Canada and the European Medicines Agency and we will file with regulatory agencies around the world for this important younger age population." The vaccine developed by Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.05% and BioNTech SE /zigman2/quotes/214419716/composite BNTX +5.04% has already been granted EUA for adolescents. Moderna's stock has soared 108.1% year to date through Wednesday, while the Pfizer shares have gained 8.2% and the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.54% has advanced 12.3%.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 353.60
+7.96 +2.30%
Volume: 11.35M
July 30, 2021 4:00p
P/E Ratio
281.98
Dividend Yield
N/A
Market Cap
$141.98 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 42.81
+0.02 +0.05%
Volume: 24.76M
July 30, 2021 4:03p
P/E Ratio
18.33
Dividend Yield
3.64%
Market Cap
$239.64 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 328.35
+15.76 +5.04%
Volume: 4.03M
July 30, 2021 4:00p
P/E Ratio
58.10
Dividend Yield
N/A
Market Cap
$79.30 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,395.26
-23.89 -0.54%
Volume: 2.25B
July 30, 2021 5:06p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.